Development-inspired reprogramming of the mammalian central nervous system.
In 2012, John Gurdon and Shinya Yamanaka shared the Nobel Prize for the demonstration that the identity of differentiated cells is not irreversibly determined but can be changed back to a pluripotent state under appropriate instructive signals. The principle that differentiated cells can revert to an embryonic state and even be converted directly from one cell type into another not only turns fundamental principles of development on their heads but also has profound implications for regenerative medicine. Replacement of diseased tissue with newly reprogrammed cells and modeling of human disease are concrete opportunities. Here, we focus on the central nervous system to consider whether and how reprogramming of cell identity may affect regeneration and modeling of a system historically considered immutable and hardwired.
Department of Stem Cell and Regenerative Biology, Sherman Fairchild Building, 7 Divinity Avenue, Harvard University, Cambridge, MA 02138, USA.
Ryoji
R
Amamoto
Paola
P
Arlotta
D000818:Animals; D001253:Astrocytes / Q000166:cytology; D019070:Cell Lineage / Q000235:genetics / Q000502:physiology; D065150:Cellular Reprogramming / Q000235:genetics / Q000502:physiology*; D002490:Central Nervous System / Q000166:cytology* / Q000196:embryology*; D005347:Fibroblasts / Q000166:cytology; D022781:Hepatocytes / Q000166:cytology; D006801:Humans; D008322:Mammals / Q000196:embryology*; D008938:Mitosis / Q000235:genetics / Q000502:physiology; D055495:Neurogenesis / Q000235:genetics / Q000502:physiology*; D009474:Neurons / Q000166:cytology*; D014157:Transcription Factors / Q000378:metabolism
D014157:Transcription Factors